Pay in 4 interest-free payments of $7.23 Learn more
Ships within 48 hours · Estimated delivery Aug 30 - Sep 4
GLP-1 receptor agonists mimic gut hormones to curb appetite and slow digestion, a mechanism driving the success of therapies from Novo Nordisk (Ozempic for diabetes and Wegovy for weight loss) and Lilly (Mounjaro for diabetes and Zepbound for weight loss)
Experts say these side-effects can relate to the way the medications work: slowing the progress of food through the digestive tract, slowing stomach emptying and affecting signalling from the gut to the brain
Darji says GLP-1 medications were originally created to treat type 2 diabetes, since they can help stabilize blood sugar levels and lower post-meal glucose spikes
Reduced anxiety and depression, which are common comorbidities of obesity, may contribute to enhanced libido and sexual satisfaction
US$ 21.23
US$ 29.83
US$ 25.28
US$ 23.49
US$ 27.21
US$ 29.02
US$ 29.31
